Tactogen

📍 Palo Alto, United States🗓 Founded 2020👥 8 employees💰 Last funded Oct 2020
Biotechnology Research🌐 tactogen.com
Website LinkedIn
Safe, Effective Prescription Mental Wellness. For Everyone. Tactogen is a pharmatech startup developing the next generation of MDMA-like medicines. Founded by Genentech data science leader and PhD neuroscientist Matthew Baggott and deeptech serial entrepreneur Luke Pustejovsky, Compared to existing psychedelics, our gentler, less euphoric compounds can facilitate psychotherapy, decision-making, and psychological growth while having less need for the expensive clinical monitoring. Our IP includes drug discovery methods, novel molecules, and pharmaceutical preparations. These all focus on one goal: enabling safer take-home prescription empathogens. We believe this will be the key to effective and accessible mental wellness. Tactogen: Effective Prescription Mental Wellness. For Everyone.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Tactogen?
Tactogen has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Tactogen last raise funding?
The most recent investment in Tactogen recorded on gritt.io was in October 2020.
When was Tactogen founded?
Tactogen was founded in 2020.
What industry is Tactogen in?
Tactogen operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Tactogen based?
Tactogen is headquartered in Palo Alto, United States.